Company profile · Biotech & medical
HCmed Innovations
心誠鎂行動醫電股份有限公司 · 6934
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
HCmed Innovations develops vibrating mesh nebulizers and provides integrated development and manufacturing services for drug-nebulizer combination products.[1]
The company's vibrating mesh nebulizers generate a 3–5 μm drug aerosol that allows patients to deliver medication to the lower respiratory tract for conditions such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and respiratory infections.[2]
HCmed Innovations offers contract development and manufacturing services (CDMO) to assist pharmaceutical companies in optimizing drug delivery performance and efficiency.[1]
The company is based in Taipei City, Taiwan.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$0m | -88.4% | -99.9% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$0m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | HCmed Innovations Co., Ltd. |
|---|---|
| Chinese name | 心誠鎂行動醫電股份有限公司 |
| Stock code | 6934 (TWSE) |
| Industry | Biotech & medical |
| Founded | 06 Oct 2014 |
| Listed | 02 Feb 2026 |
| Paid-in capital | NT$361m |
| Chairman | 鄭傑升 |
| President | 鄭傑升 |
| Headquarters | 10F., No.319, Sec.2, Dunhua S Rd Taipei City 10669, Taiwan |
| Website | https://www.hcmed-inno.com |
| Official business description | 呼吸藥物藥械投藥系統委託開發暨生產服務(CDMO) |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 心誠鎂行動醫電股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list